| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f09dc5d2579dd59087f1d0376500ea32 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T292-67 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/E05B65-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21 |
| filingDate |
1992-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4658714ad784696c097ed37cab6c514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d82ddd0cb33a70ad872f2ad29b7e2e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b473175a615a892de0242f9e9ec0324d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b279b53fece7c97673b76dfe682eb92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6a594fd629741fb46c8e3ca2f7b2f17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_784b65b7a129926491069e30be5fa073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0596aceacd077009e6fbca2a65ae1b27 |
| publicationDate |
1992-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9221377-A1 |
| titleOfInvention |
Peptides for use in induction of t cell activation against hiv-1 |
| abstract |
Peptides corresponding to regions of the human immunodeficiency virus protein gp-120 are provided for eliciting T-cell activation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5603933-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6210873-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9423746-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5589175-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6265539-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9518148-A1 |
| priorityDate |
1991-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |